Wallace Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Wallace Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,650	Closed	-$223K	–	75
2025 Q1	$223K	Hold	3,650	–	–	0.03%	68
2024 Q4	$206K	Buy	+3,650	New	+$204K	0.03%	75
2014 Q2	–	Sell	-21,235	Closed	-$1.1M	–	56
2014 Q1	$1.1M	Hold	21,235	–	–	0.24%	44
2013 Q4	$1.13M	Hold	21,235	–	–	0.26%	44
2013 Q3	$983K	Hold	21,235	–	–	0.27%	44
2013 Q2	$949K	Buy	+21,235	New	+$922K	0.29%	48

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wallace Capital Management's BMY Position: Q2 2025 in Review

Wallace Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,650 shares — an estimated $223K sold.

Wallace Capital Management first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $1.13M in Q4 2013. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Wallace Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Wallace Capital Management sold 3,650 Bristol-Myers Squibb shares in Q2 2025, an estimated $223K.
Wallace Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
Wallace Capital Management's Bristol-Myers Squibb position peaked at $1.13M in Q4 2013.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Wallace Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.